67 related articles for article (PubMed ID: 8457238)
1. Pharmacokinetic study of 4'-acetamidophenyl-2-(5'-p-toluyl-1'-methylpyrrole)acetate in the rat.
Sabater J; Domenéch J; Obach R
Arzneimittelforschung; 1993 Feb; 43(2):154-9. PubMed ID: 8457238
[TBL] [Abstract][Full Text] [Related]
2. On the mechanism of the pharmacological activity of the new nonsteroidal antiinflammatory agent 4'-acetamidophenyl-2-(5'-p-toluyl-1'-methylpyrrole)acetate.
Ucelay M; Lasheras B; Cenarruzabeitia E
Arzneimittelforschung; 1989 May; 39(5):586-9. PubMed ID: 2757675
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological study of the new nonsteroidal antiinflammatory agent 4'-acetamidophenyl-2-(5'-p-toluyl-1'-methylpyrrole)acetate.
Ucelay M; Lasheras B; Cenarruzabeitia E
Arzneimittelforschung; 1988 Apr; 38(4):546-51. PubMed ID: 3401269
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of the gastrointestinal tolerability of tolmetin and 4'-acetamidophenyl-2-(5'-p-toluyl-1'-methylpyrrole) acetate (AU-8001).
Rimbau V; Fernández E; Torralba A; Sabater J
Arzneimittelforschung; 1983; 33(6):831-3. PubMed ID: 6604531
[TBL] [Abstract][Full Text] [Related]
5. [Preliminary pharmacological studies of a new anti-inflammatory agent: 4'-acetamidophenyl-2-(5'-p-toluyl-1'-methylpyrrole)acetate].
Cenarruzabeitia E; Lasheras B; Fontan JL
Boll Chim Farm; 1982 Mar; 121(3):97-105. PubMed ID: 6982052
[No Abstract] [Full Text] [Related]
6. Reduction of oral bioavailability of paracetamol by tolmetin in rat.
Sabater J; Peraire C; Obach R; Moreno J; Domenech J
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():61-5. PubMed ID: 1820937
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic study of tolmetin in the rat.
Sabater J; Domenéch J; Obach R
Arzneimittelforschung; 1992 Jul; 42(7):950-3. PubMed ID: 1418060
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological properties and toxicology of MED-15, a prodrug of tolmetin.
Caruso A; Cutuli VM; De Bernardis E; Attaguile G; Amico-Roxas M
Drugs Exp Clin Res; 1992; 18(11-12):481-5. PubMed ID: 1308474
[TBL] [Abstract][Full Text] [Related]
10. A population model for tolmetin pharmacokinetics in rats considering saturable elimination.
Pérez-Urizar J; De Trocóniz IF; Ibarra AE; Flores-Murrieta FJ; Castañeda-Hernández G
Proc West Pharmacol Soc; 2001; 44():135-7. PubMed ID: 11793960
[No Abstract] [Full Text] [Related]
11. Characterization of the pharmacokinetics of dioscin in rat.
Li K; Tang Y; Fawcett JP; Gu J; Zhong D
Steroids; 2005 Jul; 70(8):525-30. PubMed ID: 15894036
[TBL] [Abstract][Full Text] [Related]
12. Passive versus electrotransport-facilitated transdermal absorption of ketorolac.
Park K; Verotta D; Gupta SK; Sheiner LB
Clin Pharmacol Ther; 1998 Mar; 63(3):303-15. PubMed ID: 9542474
[TBL] [Abstract][Full Text] [Related]
13. Enhanced paclitaxel bioavailability after oral coadministration of paclitaxel prodrug with naringin to rats.
Choi JS; Shin SC
Int J Pharm; 2005 Mar; 292(1-2):149-56. PubMed ID: 15725561
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic evaluation of indomethacin ethyl ester-loaded nanoencapsules.
Cattani VB; Pohlmann AR; Dalla Costa T
Int J Pharm; 2008 Nov; 363(1-2):214-6. PubMed ID: 18678236
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetic and pharmacodynamic profile of the trioxyethylene ester of indomethacin in a new oral prodrug].
Palagiano F; de Caprariis P; Bonina FP; Montenegro L; Capasso A; Sorrentino L
Boll Chim Farm; 1996 Feb; 135(2):89-91. PubMed ID: 9044565
[No Abstract] [Full Text] [Related]
16. Decrease in oral bioavailability of ciclosporin by intravenous pulse of methylprednisolone succinate in rats.
Konishi H; Sumi M; Shibata N; Takada K; Minouchi T; Yamaji A
J Pharm Pharmacol; 2004 Oct; 56(10):1259-66. PubMed ID: 15482640
[TBL] [Abstract][Full Text] [Related]
17. Distribution and quantitation of the anti-trypanosomal diamidine 2,5-bis(4-amidinophenyl)furan (DB75) and its N-methoxy prodrug DB289 in murine brain tissue.
Sturk LM; Brock JL; Bagnell CR; Hall JE; Tidwell RR
Acta Trop; 2004 Jul; 91(2):131-43. PubMed ID: 15234662
[TBL] [Abstract][Full Text] [Related]
18. Disposition and metabolism of a novel prostanoid antiglaucoma medication, tafluprost, following ocular administration to rats.
Fukano Y; Kawazu K
Drug Metab Dispos; 2009 Aug; 37(8):1622-34. PubMed ID: 19477946
[TBL] [Abstract][Full Text] [Related]
19. Enantiospecific disposition of pranoprofen in beagle dogs and rats.
Imai T; Nomura T; Aso M; Otagiri M
Chirality; 2003 May; 15(4):312-7. PubMed ID: 12666237
[TBL] [Abstract][Full Text] [Related]
20. [A bioequivalence study of tablet and powder formulations of the nonsteroidal anti-inflammatory drug 2-methoxyphenyl 1-methyl-5-(p-methylbenzoylpyrrol)-2-acetamidoacetate].
Annunziato L; di Renzo G
Clin Ter; 1993 Jan; 142(1 Pt 2):11-7. PubMed ID: 8472516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
